M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Operating Income Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Operating Income
-€19.9m
CAGR 3-Years
-56%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Operating Income
-€136.2m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
G
Genfit SA
PAR:GNFT
Operating Income
€23.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inventiva SA
PAR:IVA
Operating Income
-€100m
CAGR 3-Years
-42%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Operating Income
€13.7m
CAGR 3-Years
-49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
OSE Immunotherapeutics SA
PAR:OSE
Operating Income
€53.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Operating Income?
Operating Income
-19.9m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Operating Income amounts to -19.9m EUR.

What is Maat Pharma SA's Operating Income growth rate?
Operating Income CAGR 5Y
-35%

Over the last year, the Operating Income growth was -47%. The average annual Operating Income growth rates for Maat Pharma SA have been -56% over the past three years , -35% over the past five years .

Back to Top